Skip to content

Privacy and enquiry notice

Medlexion Technologies LLP is responsible for the personal data you submit through this enquiry. EvidenceOS is the system used to receive, review and keep the enquiry record. For privacy questions or a verified rights request, email support@medlexion.com.

For a national India micro/small enterprise free enquiry, we use your name, email address, a short description, and any optional business name or stage, to decide whether a human can review your question, establish a restricted private reference, contact you if capacity permits, preserve a proportionate enquiry audit, and prevent abuse. No legal proceeding, payment, external document upload, marketing subscription or AI-model submission starts with this form.

We also keep bounded context about how the enquiry reached us, such as the page, campaign, referral, partner or outreach identifiers and first-arrival timing. These fields help us understand and deduplicate acquisition routes. A referral link does not give a partner access to your enquiry or documents, and you should never put names, email addresses or private case details into a referral URL.

At this stage, send only a brief description. Do not send health information, identity documents, bank or account numbers, passwords, OTPs, or confidential details about other people in the description. Documents are optional and can be sent only when an upload control is available. Accepted files enter quarantine. Receipt does not mean a file has been cleared or reviewed as evidence. You can enquire without files.

Sending the form does not appoint a representative, start a filing, pause a deadline or create a paid engagement. Any proposed service, contracting scope, price, tax treatment and terms require a separate reviewed step and explicit acceptance. Submitting an enquiry does not sign you up for marketing.

Creator and community collaboration interests

Our optional collaboration-interest form is separate from customer problem enquiries. It asks for your own professional contact name and email, public HTTPS profile, organisation if provided, principal countries or audiences, topics, proposed format, preferred editorial or performance-based partnership discussion and a short proposal. Use only details you are authorised to share. Do not include audience member enquiries, confidential client files or another person's sensitive data.

We use these details to let an authorised human assess whether a potential editorial, educational or community discussion makes sense, prevent duplicate or abusive submissions, and reply to your own request when appropriate. We may record whether the form was reached through a private creator-invitation link, but a forwarded invitation does not verify your identity or establish the inviter's endorsement. Your form submission does not give consent for unrelated marketing or create an affiliate, referral, endorsement, licensing, fee or service contract. An indication of interest in a performance-based model does not establish entitlement to earnings or any legally permitted referral activity; a separate current written agreement, disclosures and service/country permissions are required. Publication and use of any material would require a separate reviewed permission.

These collaboration records are placed into retention review after 90 days and may be restricted or deleted as appropriate, subject to documented legal and security holds. The access, international processing safeguards and contact-for-rights information below apply to collaboration enquiries too. If you only want to ask a privacy question, email support@medlexion.com instead of submitting a form.

Service providers

Access is limited to authorised Medlexion operators and providers needed to run the enquiry service. The enquiry service uses application hosting, a managed database, transactional email, operator authentication and encrypted backup storage. Public pages may be served separately from the private application. Customer records are not intended to be stored in personal Gmail or public file storage. Sending an enquiry never charges you. Any paid step requires a separate offer and acceptance.

Medlexion is established in India. Its current private application and managed database operate in the Frankfurt region, and existing encrypted recovery backups use a Cloudflare R2 EU-jurisdiction bucket. Authorised operators may access the service from India. This is international technical processing, not a representation that financial transaction originals have an Indian storage location. Any later paid engagement and financial-record processing require a separate actual-scope and legal review.

If an authorised matter later requires restricted Google Workspace case custody, the existing technical Workspace is hosted by a separate corporate administrator under a limited written shared custody authorisation. Medlexion remains responsible for purposes, permissions and disclosures; the technical custodian is not entitled to use Medlexion records for its own matters. Case-specific documents, processor recipients and AI use require further approval. The initial India MSE free enquiry does not automatically create a Drive case folder or transfer customer documents.

Later-stage document assistance and authorized technology providers

The initial enquiry is different from an accepted case engagement. If you separately proceed with a service that involves reviewing documents, Medlexion may propose to use access-controlled digital case workspaces and specialist document-analysis or AI-assisted drafting services. Depending on the approved task, these services could process evidence, correspondence, identity and contact details, submissions from other parties, procedural records and work product. We will tell you about the relevant purpose and requested categories before enabling such processing; the initial enquiry does not by itself authorize transferring your full case files to these systems.

Authorized operators and appropriate service providers may receive access only where necessary for the agreed purpose and subject to the applicable confidentiality, security, contract and access controls. Processing may take place outside your country, including through service providers and their authorized subprocessors. International transfers, provider roles and safeguards must be assessed for the actual arrangement. We will provide further information about relevant provider identities and applicable safeguards when required by law or upon an appropriate verified privacy request.

We do not treat permission to prepare a document as automatic permission for unrelated model development or training. Whether any provider processes information to improve its systems depends on its service terms and the controls actually configured; customer case documents must not be supplied for such use without an independently reviewed lawful purpose, appropriate notice and permissions. We review automated draft outputs before any authorized filing or customer delivery, and no initial enquiry creates a solely automated decision about your legal rights.

Where applicable, you can ask about available non-AI handling alternatives and the consequences for the service, subject to technical feasibility and professional requirements. Records and draft work products are retained under applicable case and legal retention schedules, not automatically deleted when a conversation closes. Contact support@medlexion.com for a verified request about processing, access, correction, deletion, objection or other rights available under applicable law.

How long we keep it

An enquiry that does not become an active engagement is placed into a retention review after 90 days of inactivity. This is a review checkpoint, not a guarantee that every copy is deleted on day 90. Subject to applicable rights and documented security, dispute, regulatory, accounting or other lawful preservation reasons, the record may then be deleted or minimised. Security-event records and encrypted production recovery copies are subject to their separate evidence-preservation and restoration schedules. They are not automatically erased when an enquiry is closed; nor is indefinite retention assumed. Medlexion can review and document an applicable request or hold through its restricted privacy-rights process.

Your choices and rights

Depending on the law that applies to you and the processing, you may have rights to ask for access, correction, deletion, restriction or objection. Email support@medlexion.com with your enquiry reference. We may need to verify identity and may have to retain some records where a legal hold, contractual, accounting, security or other lawful record obligation applies.

How a verified privacy request is handled

You may write to support@medlexion.com with your reference and the requested change, withdrawal, access, correction, erasure, grievance or other available right. Please do not include passwords, OTPs or unnecessary identification documents in your first message. Our operator records an original-source reference, conducts an appropriate identity and case-scope review, checks lawful retention and third-party obligations and documents any actual response. Requests do not cause automatic deletion of legally preserved evidence or data held by outside providers. We will respond according to the law that actually applies, including when a statutory provision has not yet commenced.

In India, under the 13 November 2025 DPDP notifications, the Consent Manager registration phase is scheduled for 13 November 2026, while the broader notice, fiduciary and individual-rights provisions are scheduled for 13 May 2027. Medlexion is not representing itself as a registered Consent Manager. We are preparing the rights workflow in advance, while applying all other existing privacy, confidentiality and cybersecurity requirements now. These Indian dates do not automatically govern people in other countries.

Keep any private enquiry or progress link secure. We do not add advertising pixels to the enquiry form or private progress page.

Historical/general customer enquiry notice version: rc59-intake-2026-09-27. National India MSE free-enquiry notice version: india-mse-free-2026-11-08. Later-stage document-processing notice version: ai-casework-processing-2026-10-30-v1. Creator collaboration notice version: creator-collaboration-2026-10-22. Creator-specific disclosure updated 22 October 2026. Rights-handling process addendum RC239 dated 7 November 2026. For current privacy information or help, contact support@medlexion.com.